Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019.Emerg Infect Dis. 2019 11; 25(11):2108-2111.EI
Abstract
In 2019, influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic gene, which confers reduced susceptibility to baloxavir, were detected in Japan in an infant without baloxavir exposure and a baloxavir-treated sibling. These viruses' whole-genome sequences were identical, indicating human-to-human transmission. Influenza virus isolates should be monitored for baloxavir susceptibility.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
31436527
Clinical Trial Links
Citation
Takashita, Emi, et al. "Human-to-Human Transmission of Influenza A(H3N2) Virus With Reduced Susceptibility to Baloxavir, Japan, February 2019." Emerging Infectious Diseases, vol. 25, no. 11, 2019, pp. 2108-2111.
Takashita E, Ichikawa M, Morita H, et al. Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019. Emerg Infect Dis. 2019;25(11):2108-2111.
Takashita, E., Ichikawa, M., Morita, H., Ogawa, R., Fujisaki, S., Shirakura, M., Miura, H., Nakamura, K., Kishida, N., Kuwahara, T., Sugawara, H., Sato, A., Akimoto, M., Mitamura, K., Abe, T., Yamazaki, M., Watanabe, S., Hasegawa, H., & Odagiri, T. (2019). Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019. Emerging Infectious Diseases, 25(11), 2108-2111. https://doi.org/10.3201/eid2511.190757
Takashita E, et al. Human-to-Human Transmission of Influenza A(H3N2) Virus With Reduced Susceptibility to Baloxavir, Japan, February 2019. Emerg Infect Dis. 2019;25(11):2108-2111. PubMed PMID: 31436527.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019.
AU - Takashita,Emi,
AU - Ichikawa,Masataka,
AU - Morita,Hiroko,
AU - Ogawa,Rie,
AU - Fujisaki,Seiichiro,
AU - Shirakura,Masayuki,
AU - Miura,Hideka,
AU - Nakamura,Kazuya,
AU - Kishida,Noriko,
AU - Kuwahara,Tomoko,
AU - Sugawara,Hiromi,
AU - Sato,Aya,
AU - Akimoto,Miki,
AU - Mitamura,Keiko,
AU - Abe,Takashi,
AU - Yamazaki,Masahiko,
AU - Watanabe,Shinji,
AU - Hasegawa,Hideki,
AU - Odagiri,Takato,
Y1 - 2019/11/17/
PY - 2019/8/23/pubmed
PY - 2020/4/9/medline
PY - 2019/8/23/entrez
KW - H3N2
KW - I38T substitution
KW - Japan
KW - antimicrobial resistance
KW - baloxavir
KW - baloxavir acid
KW - baloxavir marboxil
KW - cap-dependent endonuclease inhibitor
KW - family cluster
KW - human-to-human transmission
KW - influenza
KW - influenza A(H1N1)pdm09
KW - influenza virus
KW - polymerase acidic
KW - respiratory infections
KW - viruses
KW - whole-genome sequencing
SP - 2108
EP - 2111
JF - Emerging infectious diseases
JO - Emerg Infect Dis
VL - 25
IS - 11
N2 - In 2019, influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic gene, which confers reduced susceptibility to baloxavir, were detected in Japan in an infant without baloxavir exposure and a baloxavir-treated sibling. These viruses' whole-genome sequences were identical, indicating human-to-human transmission. Influenza virus isolates should be monitored for baloxavir susceptibility.
SN - 1080-6059
UR - https://www.unboundmedicine.com/medline/citation/31436527/Human_to_Human_Transmission_of_Influenza_A_H3N2__Virus_with_Reduced_Susceptibility_to_Baloxavir_Japan_February_2019_
DB - PRIME
DP - Unbound Medicine
ER -